Keywords
Last Name
Institution

Kevin P Claffey PhD

TitleProfessor
InstitutionUConn Health Center
DepartmentCell Biology
AddressMC 3501
MC 3501
263 Farmington Avenue
Phone860-679-8713
Fax860-679-1201
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Devarakonda CV, Kita D, Phoenix KN, Claffey KP. Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors. BMC Cancer. 2015; 15:614. PMID: 26334999; PMCID: PMC4559304.
    2. Dong H, Claffey KP, Brocke S, Epstein PM. Inhibition of breast cancer cell migration by activation of cAMP signaling. Breast Cancer Res Treat. 2015 Jul; 152(1):17-28. PMID: 26022351.
      View in: PubMed
    3. Jensen T, Vadasz S, Phoenix K, Claffey K, Parikh N, Finck C. Descriptive analysis of tumor cells with stem like phenotypes in metastatic and benign adrenal tumors. J Pediatr Surg. 2015 Sep; 50(9):1493-501. PMID: 25976447.
      View in: PubMed
    4. Wang Y, Cao Y, Yamada S, Thirunavukkarasu M, Nin V, Joshi M, Rishi MT, Bhattacharya S, Camacho-Pereira J, Sharma AK, Shameer K, Kocher JP, Sanchez JA, Wang E, Hoeppner LH, Dutta SK, Leof EB, Shah V, Claffey KP, Chini EN, Simons M, Terzic A, Maulik N, Mukhopadhyay D. Cardiomyopathy and Worsened Ischemic Heart Failure in SM22-a Cre-Mediated Neuropilin-1 Null Mice: Dysregulation of PGC1a and Mitochondrial Homeostasis. Arterioscler Thromb Vasc Biol. 2015 Jun; 35(6):1401-12. PMID: 25882068; PMCID: PMC4441604 [Available on 06/01/16].
    5. Choudhary D, Hegde P, Voznesensky O, Choudhary S, Kopsiaftis S, Claffey KP, Pilbeam CC, Taylor JA. Increased expression of L-selectin (CD62L) in high-grade urothelial carcinoma: A potential marker for metastatic disease. Urol Oncol. 2015 Sep; 33(9):387.e17-27. PMID: 25618296; PMCID: PMC4510033 [Available on 09/01/16].
    6. Lai LP, Gibson-Gill CM, Gombas G, Claffey K, Tanks S, Garstang S. Hydronephrosis: an unusual complication of neurogenic bowel in a patient with spinal cord injury: a case report. Spinal Cord. 2014 Jun; 52 Suppl 1:S9-10. PMID: 24902647.
      View in: PubMed
    7. Dong H, Claffey KP, Brocke S, Epstein PM. Expression of phosphodiesterase 6 (PDE6) in human breast cancer cells. Springerplus. 2013; 2:680. PMID: 24683528; PMCID: PMC3967736.
    8. Hutchins-Wiese HL, Picho K, Watkins BA, Li Y, Tannenbaum S, Claffey K, Kenny AM. High-dose eicosapentaenoic acid and docosahexaenoic acid supplementation reduces bone resorption in postmenopausal breast cancer survivors on aromatase inhibitors: a pilot study. Nutr Cancer. 2014; 66(1):68-76. PMID: 24274259.
      View in: PubMed
    9. Fox MM, Phoenix KN, Kopsiaftis SG, Claffey KP. AMP-Activated Protein Kinase a 2 Isoform Suppression in Primary Breast Cancer Alters AMPK Growth Control and Apoptotic Signaling. Genes Cancer. 2013 Jan; 4(1-2):3-14. PMID: 23946867; PMCID: PMC3743155.
    10. Murphy M, Phelps A, Swede H, Claffey K. Hypoxia-induced response of cell cycle and apoptosis regulators in melanoma. Int J Dermatol. 2012 Oct; 51(10):1263-7. PMID: 22994674.
      View in: PubMed
    11. Grant CL, Caromile LA, Ho V, Durrani K, Rahman MM, Claffey KP, Fong GH, Shapiro LH. Prostate specific membrane antigen (PSMA) regulates angiogenesis independently of VEGF during ocular neovascularization. PLoS One. 2012; 7(7):e41285. PMID: 22815987; PMCID: PMC3399825.
    12. Kamath J, Cruess DG, Claffey K, Wilson L, Phoenix N, Tannenbaum S. Symptom distress associated with biopsy in women with suspect breast lesions. ISRN Oncol. 2012; 2012:898327. PMID: 22830048; PMCID: PMC3399343.
    13. Hoeppner LH, Phoenix KN, Clark KJ, Bhattacharya R, Gong X, Sciuto TE, Vohra P, Suresh S, Bhattacharya S, Dvorak AM, Ekker SC, Dvorak HF, Claffey KP, Mukhopadhyay D. Revealing the role of phospholipase Cß3 in the regulation of VEGF-induced vascular permeability. Blood. 2012 Sep 13; 120(11):2167-73. PMID: 22674805; PMCID: PMC3447777.
    14. Phoenix KN, Devarakonda CV, Fox MM, Stevens LE, Claffey KP. AMPKa2 Suppresses Murine Embryonic Fibroblast Transformation and Tumorigenesis. Genes Cancer. 2012 Jan; 3(1):51-62. PMID: 22893790; PMCID: PMC3415672.
    15. Biswal NC, Pavlik C, Smith MB, Aguirre A, Xu Y, Zanganeh S, Kuhn LT, Claffey KP, Zhu Q. Imaging tumor hypoxia by near-infrared fluorescence tomography. J Biomed Opt. 2011 Jun; 16(6):066009. PMID: 21721810; PMCID: PMC3133800.
    16. Guttilla IK, Phoenix KN, Hong X, Tirnauer JS, Claffey KP, White BA. Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs. Breast Cancer Res Treat. 2012 Feb; 132(1):75-85. PMID: 21553120.
      View in: PubMed
    17. Fang M, Toher J, Morgan M, Davison J, Tannenbaum S, Claffey K. Genomic differences between estrogen receptor (ER)-positive and ER-negative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis. Cancer. 2011 May 15; 117(10):2024-34. PMID: 21523713; PMCID: PMC4521590.
    18. Zheng J, Machida K, Antoku S, Ng KY, Claffey KP, Mayer BJ. Proteins that bind the Src homology 3 domain of CrkI have distinct roles in Crk transformation. Oncogene. 2010 Dec 2; 29(48):6378-89. PMID: 20729917; PMCID: PMC2996469.
    19. Rezaul K, Thumar JK, Lundgren DH, Eng JK, Claffey KP, Wilson L, Han DK. Differential protein expression profiles in estrogen receptor-positive and -negative breast cancer tissues using label-free quantitative proteomics. Genes Cancer. 2010 Mar; 1(3):251-71. PMID: 21779449; PMCID: PMC3092194.
    20. Phoenix KN, Vumbaca F, Fox MM, Evans R, Claffey KP. Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy. Breast Cancer Res Treat. 2010 Sep; 123(2):333-44. PMID: 20204498; PMCID: PMC2888909.
    21. Adams BD, Claffey KP, White BA. Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells. Endocrinology. 2009 Jan; 150(1):14-23. PMID: 18787018; PMCID: PMC2630894.
    22. Rodriguez-Pinto D, Sparkowski J, Keough MP, Phoenix KN, Vumbaca F, Han DK, Gundelfinger ED, Beesley P, Claffey KP. Identification of novel tumor antigens with patient-derived immune-selected antibodies. Cancer Immunol Immunother. 2009 Feb; 58(2):221-34. PMID: 18568347; PMCID: PMC2833102.
    23. Nakanishi M, Montrose DC, Clark P, Nambiar PR, Belinsky GS, Claffey KP, Xu D, Rosenberg DW. Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis. Cancer Res. 2008 May 1; 68(9):3251-9. PMID: 18451151.
      View in: PubMed
    24. Peluso JJ, Liu X, Saunders MM, Claffey KP, Phoenix K. Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1. J Clin Endocrinol Metab. 2008 May; 93(5):1592-9. PMID: 18319313.
      View in: PubMed
    25. Phoenix KN, Vumbaca F, Claffey KP. Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model. Breast Cancer Res Treat. 2009 Jan; 113(1):101-11. PMID: 18256928; PMCID: PMC2606917.
    26. Wang Z, Liu B, Wang P, Dong X, Fernandez-Hernando C, Li Z, Hla T, Li Z, Claffey K, Smith JD, Wu D. Phospholipase C beta3 deficiency leads to macrophage hypersensitivity to apoptotic induction and reduction of atherosclerosis in mice. J Clin Invest. 2008 Jan; 118(1):195-204. PMID: 18079968; PMCID: PMC2129238.
    27. Vumbaca F, Phoenix KN, Rodriguez-Pinto D, Han DK, Claffey KP. Double-stranded RNA-binding protein regulates vascular endothelial growth factor mRNA stability, translation, and breast cancer angiogenesis. Mol Cell Biol. 2008 Jan; 28(2):772-83. PMID: 18039850; PMCID: PMC2223436.
    28. Skoura A, Sanchez T, Claffey K, Mandala SM, Proia RL, Hla T. Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. J Clin Invest. 2007 Sep; 117(9):2506-16. PMID: 17710232; PMCID: PMC1940238.
    29. Taylor JA, Kuchel GA, Hegde P, Voznesensky OS, Claffey K, Tsimikas J, Leng L, Bucala R, Pilbeam C. Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice. BMC Cancer. 2007; 7:135. PMID: 17650334; PMCID: PMC1939709.
    30. Backer MV, Levashova Z, Patel V, Jehning BT, Claffey K, Blankenberg FG, Backer JM. Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes. Nat Med. 2007 Apr; 13(4):504-9. PMID: 17351626.
      View in: PubMed
    31. Bagnato C, Thumar J, Mayya V, Hwang SI, Zebroski H, Claffey KP, Haudenschild C, Eng JK, Lundgren DH, Han DK. Proteomics analysis of human coronary atherosclerotic plaque: a feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics. 2007 Jun; 6(6):1088-102. PMID: 17339633.
      View in: PubMed
    32. Backer MV, Patel V, Jehning BT, Claffey KP, Karginov VA, Backer JM. Inhibition of anthrax protective antigen outside and inside the cell. Antimicrob Agents Chemother. 2007 Jan; 51(1):245-51. PMID: 17074791; PMCID: PMC1797656.
    33. Backer MV, Patel V, Jehning BT, Claffey KP, Backer JM. Surface immobilization of active vascular endothelial growth factor via a cysteine-containing tag. Biomaterials. 2006 Nov; 27(31):5452-8. PMID: 16843524.
      View in: PubMed
    34. Neurath KM, Keough MP, Mikkelsen T, Claffey KP. AMP-dependent protein kinase alpha 2 isoform promotes hypoxia-induced VEGF expression in human glioblastoma. Glia. 2006 May; 53(7):733-43. PMID: 16518831.
      View in: PubMed
    35. Muñoz-Nájar UM, Neurath KM, Vumbaca F, Claffey KP. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation. Oncogene. 2006 Apr 13; 25(16):2379-92. PMID: 16369494.
      View in: PubMed
    36. Backer MV, Gaynutdinov TI, Patel V, Bandyopadhyaya AK, Thirumamagal BT, Tjarks W, Barth RF, Claffey K, Backer JM. Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature. Mol Cancer Ther. 2005 Sep; 4(9):1423-9. PMID: 16170035.
      View in: PubMed
    37. Belinsky GS, Claffey KP, Nambiar PR, Guda K, Rosenberg DW. Vascular endothelial growth factor and enhanced angiogenesis do not promote metastatic conversion of a newly established azoxymethane-induced colon cancer cell line. Mol Carcinog. 2005 Jun; 43(2):65-74. PMID: 15768385.
      View in: PubMed
    38. Bhisitkul RB, Robinson GS, Moulton RS, Claffey KP, Gragoudas ES, Miller JW. An antisense oligodeoxynucleotide against vascular endothelial growth factor in a nonhuman primate model of iris neovascularization. Arch Ophthalmol. 2005 Feb; 123(2):214-9. PMID: 15710818.
      View in: PubMed
    39. Kluk MJ, Grant-Kels JM, Kerr P, Hoss D, Berke A, Claffey KP, Murphy M. Melanoma on the move: the progression of melanoma: novel concepts with histologic correlates. Am J Dermatopathol. 2004 Dec; 26(6):504-10. PMID: 15618934.
      View in: PubMed
    40. Murphy M, Carlson JA, Keough MP, Claffey KP, Signoretti S, Loda M. Hypoxia regulation of the cell cycle in malignant melanoma: putative role for the cyclin-dependent kinase inhibitor p27. J Cutan Pathol. 2004 Aug; 31(7):477-82. PMID: 15239677.
      View in: PubMed
    41. Agarwal A, Muñoz-Nájar U, Klueh U, Shih SC, Claffey KP. N-acetyl-cysteine promotes angiostatin production and vascular collapse in an orthotopic model of breast cancer. Am J Pathol. 2004 May; 164(5):1683-96. PMID: 15111315; PMCID: PMC1615662.
    42. Sanchez T, Estrada-Hernandez T, Paik JH, Wu MT, Venkataraman K, Brinkmann V, Claffey K, Hla T. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J Biol Chem. 2003 Nov 21; 278(47):47281-90. PMID: 12954648.
      View in: PubMed
    43. Gratton JP, Lin MI, Yu J, Weiss ED, Jiang ZL, Fairchild TA, Iwakiri Y, Groszmann R, Claffey KP, Cheng YC, Sessa WC. Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. Cancer Cell. 2003 Jul; 4(1):31-9. PMID: 12892711.
      View in: PubMed
    44. Guda K, Claffey KP, Dong M, Nambiar PR, Rosenberg DW. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors. Mol Carcinog. 2003 May; 37(1):51-9. PMID: 12720300.
      View in: PubMed
    45. Jang BC, Muñoz-Najar U, Paik JH, Claffey K, Yoshida M, Hla T. Leptomycin B, an inhibitor of the nuclear export receptor CRM1, inhibits COX-2 expression. J Biol Chem. 2003 Jan 31; 278(5):2773-6. PMID: 12468543.
      View in: PubMed
    46. Claffey KP. Molecular profiling of angiogenic markers: a step towards interpretive analysis of a complex biological function. Am J Pathol. 2002 Jul; 161(1):7-11. PMID: 12107083; PMCID: PMC1850675.
    47. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med. 2001 Feb; 7(2):192-8. PMID: 11175850.
      View in: PubMed
    48. Claffey KP, Abrams K, Shih SC, Brown LF, Mullen A, Keough M. Fibroblast growth factor 2 activation of stromal cell vascular endothelial growth factor expression and angiogenesis. Lab Invest. 2001 Jan; 81(1):61-75. PMID: 11204275.
      View in: PubMed
    49. Shih SC, Claffey KP. Role of AP-1 and HIF-1 transcription factors in TGF-beta activation of VEGF expression. Growth Factors. 2001; 19(1):19-34. PMID: 11678207.
      View in: PubMed
    50. Zhang JC, Claffey K, Sakthivel R, Darzynkiewicz Z, Shaw DE, Leal J, Wang YC, Lu FM, McCrae KR. Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5. FASEB J. 2000 Dec; 14(15):2589-600. PMID: 11099478.
      View in: PubMed
    51. Detmar M, Velasco P, Richard L, Claffey KP, Streit M, Riccardi L, Skobe M, Brown LF. Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas. Am J Pathol. 2000 Jan; 156(1):159-67. PMID: 10623663; PMCID: PMC1868649.
    52. Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, Kluk M, Volpi M, Sha'afi RI, Hla T. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell. 1999 Oct 29; 99(3):301-12. PMID: 10555146.
      View in: PubMed
    53. Manfredi MG, Lim S, Claffey KP, Seyfried TN. Gangliosides influence angiogenesis in an experimental mouse brain tumor. Cancer Res. 1999 Oct 15; 59(20):5392-7. PMID: 10537325.
      View in: PubMed
    54. Shih SC, Mullen A, Abrams K, Mukhopadhyay D, Claffey KP. Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells. J Biol Chem. 1999 May 28; 274(22):15407-14. PMID: 10336429.
      View in: PubMed
    55. del Aguila LF, Claffey KP, Kirwan JP. TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. Am J Physiol. 1999 May; 276(5 Pt 1):E849-55. PMID: 10329978.
      View in: PubMed
    56. Shih SC, Claffey KP. Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L. J Biol Chem. 1999 Jan 15; 274(3):1359-65. PMID: 9880507.
      View in: PubMed
    57. Liu XH, Kirschenbaum A, Yao S, Stearns ME, Holland JF, Claffey K, Levine AC. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis. 1999; 17(8):687-94. PMID: 10919714.
      View in: PubMed
    58. Shih SC, Claffey KP. Hypoxia-mediated regulation of gene expression in mammalian cells. Int J Exp Pathol. 1998 Dec; 79(6):347-57. PMID: 10319016; PMCID: PMC3220374.
    59. Pal S, Claffey KP, Cohen HT, Mukhopadhyay D. Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta. J Biol Chem. 1998 Oct 9; 273(41):26277-80. PMID: 9756852.
      View in: PubMed
    60. Boesiger J, Tsai M, Maurer M, Yamaguchi M, Brown LF, Claffey KP, Dvorak HF, Galli SJ. Mast cells can secrete vascular permeability factor/ vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J Exp Med. 1998 Sep 21; 188(6):1135-45. PMID: 9743532; PMCID: PMC2212544.
    61. Oku T, Tjuvajev JG, Miyagawa T, Sasajima T, Joshi A, Joshi R, Finn R, Claffey KP, Blasberg RG. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts. Cancer Res. 1998 Sep 15; 58(18):4185-92. PMID: 9751633.
      View in: PubMed
    62. Detmar M, Brown LF, Schön MP, Elicker BM, Velasco P, Richard L, Fukumura D, Monsky W, Claffey KP, Jain RK. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol. 1998 Jul; 111(1):1-6. PMID: 9665379.
      View in: PubMed
    63. Claffey KP, Shih SC, Mullen A, Dziennis S, Cusick JL, Abrams KR, Lee SW, Detmar M. Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced mRNA stability. Mol Biol Cell. 1998 Feb; 9(2):469-81. PMID: 9450968; PMCID: PMC25276.
    64. Senger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, Detmar M. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci U S A. 1997 Dec 9; 94(25):13612-7. PMID: 9391074; PMCID: PMC28354.
    65. Pal S, Claffey KP, Dvorak HF, Mukhopadhyay D. The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways. J Biol Chem. 1997 Oct 31; 272(44):27509-12. PMID: 9346879.
      View in: PubMed
    66. Provias J, Claffey K, delAguila L, Lau N, Feldkamp M, Guha A. Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery. 1997 May; 40(5):1016-26. PMID: 9149260.
      View in: PubMed
    67. Detmar M, Brown LF, Berse B, Jackman RW, Elicker BM, Dvorak HF, Claffey KP. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J Invest Dermatol. 1997 Mar; 108(3):263-8. PMID: 9036922.
      View in: PubMed
    68. Brown LF, Detmar M, Claffey K, Nagy JA, Feng D, Dvorak AM, Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. EXS. 1997; 79:233-69. PMID: 9002222.
      View in: PubMed
    69. Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Peruzzi CA, Detmar M. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol. 1996 Jul; 149(1):293-305. PMID: 8686754; PMCID: PMC1865227.
    70. Claffey KP, Robinson GS. Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis. Cancer Metastasis Rev. 1996 Jun; 15(2):165-76. PMID: 8842488.
      View in: PubMed
    71. Claffey KP, Brown LF, del Aguila LF, Tognazzi K, Yeo KT, Manseau EJ, Dvorak HF. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res. 1996 Jan 1; 56(1):172-81. PMID: 8548760.
      View in: PubMed
    72. Iruela-Arispe L, Gordon K, Hugo C, Duijvestijn AM, Claffey KP, Reilly M, Couser WG, Alpers CE, Johnson RJ. Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol. 1995 Dec; 147(6):1715-27. PMID: 7495296; PMCID: PMC1869935.
    73. Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol. 1995 May-Jun; 107(1-3):233-5. PMID: 7542074.
      View in: PubMed
    74. Claffey KP, Senger DR, Spiegelman BM. Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF/VEGF. Biochim Biophys Acta. 1995 Jan 5; 1246(1):1-9. PMID: 7811723.
      View in: PubMed
    75. Platt KA, Claffey KP, Wilkison WO, Spiegelman BM, Ross SR. Independent regulation of adipose tissue-specificity and obesity response of the adipsin promoter in transgenic mice. J Biol Chem. 1994 Nov 18; 269(46):28558-62. PMID: 7961801.
      View in: PubMed
    76. Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, Berse B, Dvorak HF. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med. 1994 Sep 1; 180(3):1141-6. PMID: 8064230; PMCID: PMC2191647.
    77. Senger DR, Brown LF, Claffey KP, Dvorak HF. Vascular permeability factor, tumor angiogenesis and stroma generation. Invasion Metastasis. 1994-1995; 14(1-6):385-94. PMID: 7544775.
      View in: PubMed
    78. Claffey KP, Wilkison WO, Spiegelman BM. Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J Biol Chem. 1992 Aug 15; 267(23):16317-22. PMID: 1644816.
      View in: PubMed
    79. Wilkison WO, Min HY, Claffey KP, Satterberg BL, Spiegelman BM. Control of the adipsin gene in adipocyte differentiation. Identification of distinct nuclear factors binding to single- and double-stranded DNA. J Biol Chem. 1990 Jan 5; 265(1):477-82. PMID: 2294115.
      View in: PubMed
    80. Lam KT, Borkan S, Claffey KP, Schwartz JH, Chobanian AV, Brecher P. Properties and differential regulation of two fatty acid binding proteins in the rat kidney. J Biol Chem. 1988 Oct 25; 263(30):15762-8. PMID: 3170609.
      View in: PubMed
    81. Sarzani R, Claffey KP, Chobanian AV, Brecher P. Hypertension induces tissue-specific gene suppression of a fatty acid binding protein in rat aorta. Proc Natl Acad Sci U S A. 1988 Oct; 85(20):7777-81. PMID: 3174661; PMCID: PMC282276.
    82. Claffey KP, Herrera VL, Brecher P, Ruiz-Opazo N. Cloning and tissue distribution of rat heart fatty acid binding protein mRNA: identical forms in heart and skeletal muscle. Biochemistry. 1987 Dec 1; 26(24):7900-4. PMID: 3427112.
      View in: PubMed
    83. Crisman TS, Claffey KP, Saouaf R, Hanspal J, Brecher P. Measurement of rat heart fatty acid binding protein by ELISA. Tissue distribution, developmental changes and subcellular distribution. J Mol Cell Cardiol. 1987 May; 19(5):423-31. PMID: 3625779.
      View in: PubMed
    Claffey's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _